Teva received Fast Track designation from the U.S. Food and Drug Administration for emrusolmin (TEV-56286), an investigational treatment for ...

Multiple System Atrophy is an unmet medical need as there are currently no FDA approved therapies to treat this life limiting, orphan designated disease.

Teva Pharmaceuticals (NYSE:TEVA) said that the U.S. FDA has granted fast track designation to its experimental therapy TEV-56286 (emrusolmin) for treating Multiple System Atrophy.

Multiple System Atrophy is a rare and debilitating disorder involving the progressive loss of nerve cells in several areas of the brain.

Sacha was suffering from an excruciating battle with Multiple Systems Atrophy, or MSA. It’s a gnarly disease. I’ve read that about 15,000-75,000 people in the United States suffer from it.

Sara Nilson was an avid advocate for animals, a horse lover and resident of Bear Valley, which she adored for the riding ...

About Multiple System Atrophy Multiple System Atrophy is a rare and debilitating disorder involving the progressive loss of nerve cells in several areas of the brain.